These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2390004)

  • 21. Effect of sustained hypertransfusion on Rauscher leukemia virus-variant A (RLV-A) infection in BALB/c mice.
    Leonardi GP; Manthos M; LoBue J; Orlic D; Mitra J
    Adv Exp Med Biol; 1988; 241():191-8. PubMed ID: 3223406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of N-(2-hydroxyethyl)-palmitamide on virus-induced sarcomas in chickens and Rauscher leukemia in mice.
    Svec P; Béderová E; Svec J
    Neoplasma; 1975; 22(5):519-24. PubMed ID: 1196434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effect of haloperidol on Rauscher murine leukemia virus.
    Wunderlich V; Fey F; Sydow G
    Arch Geschwulstforsch; 1980; 50(8):758-62. PubMed ID: 7224819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro assessment of cellular immunity to Rauscher leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293
    [No Abstract]   [Full Text] [Related]  

  • 25. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.
    Cianciolo GJ; Matthews TJ; Bolognesi DP; Snyderman R
    J Immunol; 1980 Jun; 124(6):2900-5. PubMed ID: 6246170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly.
    Borden EC; Carter WA; Sensenbrenner LL; Owens AH; Lichtenstein J; Gray GD; Neil GL; Nichol FR; Li LH
    Int J Cancer; 1974 Dec; 14(6):817-25. PubMed ID: 4156850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
    Lee JC; Horak I; Ihle JN
    J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine.
    Ruprecht RM; O'Brien LG; Rossoni LD; Nusinoff-Lehrman S
    Nature; 1986 Oct 2-8; 323(6087):467-9. PubMed ID: 3463867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of leukemogenic and immunogenic properties of leukemic cells modified by neuraminidase of non-cholera Vibrios on the model of Rauscher leukemia].
    Bratus GG; Darchuk GF
    Eksp Onkol; 1985; 7(2):56-60. PubMed ID: 3874054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced take of spontaneous murine tumors in mice treated with inhibitors of macrophage and/or NK cell function.
    Minarovits J; Karczag E; Földes I
    Neoplasma; 1989; 36(1):3-9. PubMed ID: 2704423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activation of cellular genes as affected by Rauscher leukemia virus].
    Smirnova IA; Tatosian AG; Sherban SD; Butenko ZA
    Eksp Onkol; 1984; 6(6):31-3. PubMed ID: 6084587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine models for antiretroviral therapy.
    Ruprecht RM
    Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immune response of (C57BL/6xA/Sn)F1 mice in mycoplasm-virus infection].
    Sanin AV; Pronin AV; Khorobrykh VV; Kaulen DR
    Biull Eksp Biol Med; 1979 Sep; 88(9):327-9. PubMed ID: 519025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A transplantable leukemia from mice inoculated with Rauscher leukemia virus.
    Fredrickson TN; LoBue J; Alexander PA; Schultz EF; Gordon AS
    J Natl Cancer Inst; 1972 Jun; 48(6):1597-605. PubMed ID: 5056251
    [No Abstract]   [Full Text] [Related]  

  • 36. Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s).
    Mulé JJ; Rosenstein M; Shu S; Rosenberg SA
    Cancer Res; 1985 Feb; 45(2):526-31. PubMed ID: 3881168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
    Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
    J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early changes in cellular DNA during exposure to leukemic cell RNA and Rauscher leukemogenic virus].
    Butenko ZA
    Dokl Akad Nauk SSSR; 1974; 217(3):703-4. PubMed ID: 4848539
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of dietary selenium on tumor induction by an oncogenic virus.
    Exon JH; Koller LD; Elliott SC
    Clin Toxicol; 1976; 9(2):273-9. PubMed ID: 939079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral and anticellular effects of synthetic (2'-5')-oligoadenylate (A 2' p 5' A 2' p 5' A) in Rauscher murine leukaemia.
    Kára J; Mach O; Smrt J
    Acta Virol; 1983 Nov; 27(6):477-83. PubMed ID: 6140832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.